{"id":"W2166594813","doi":"10.1158/1078-0432.ccr-13-1869","title":"Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Marsden Fund; Pfizer; Prostate Cancer Foundation","keywords":"Medicine; Docetaxel; Prostate cancer; Clinical endpoint; Internal medicine; Adverse effect; Prednisone; Urology; Phases of clinical research; Oncology; Chemotherapy; Cancer; Randomized controlled trial; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002871707,0.002378994,0.003178021,0.000690523,0.0005986916,0.001367729,0.00116174,0.002059638,0.008846075],"category_scores_gemma":[0.002366248,0.00103661,0.002051209,0.0006541135,0.001530274,0.001267434,0.0005624458,0.004202641,0.001459555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001316317,"about_ca_system_score_gemma":0.002299229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001818515,"about_ca_topic_score_gemma":0.002967958,"domain_scores_codex":[0.9988556,0.000643738,0.00005346416,0.0001864976,0.0000813763,0.0001794315],"domain_scores_gemma":[0.9978084,0.0005229879,0.0003763427,0.0001905848,0.0001182565,0.0009834029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9713117,0.01836701,0.0004085198,0.00016916,0.0004236856,0.00003457193,0.00004386528,0.0003347407,0.001492669,0.00008301969,0.0005851387,0.006745991],"study_design_scores_gemma":[0.9271469,0.07128514,0.0006783645,0.000008770119,0.00009885024,0.00001732593,0.00001005606,0.0002017905,0.0001614767,0.00007450159,0.0003090371,0.000007832344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829338,0.002362453,0.0009863664,0.0006736291,0.000732945,0.008742426,0.0012842,0.0001601735,0.002123883],"genre_scores_gemma":[0.9795909,0.001744306,0.001783689,0.001453622,0.0005640229,0.008522455,0.001549143,0.00004033327,0.004751642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008846075,"threshold_uncertainty_score":0.02959305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.213024909223242,"score_gpt":0.5482458703631305,"score_spread":0.3352209611398885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}